Biotechnology

The leading edge of Hetero Group, Hetero Biopharma, is steadily establishing itself as a path breaking Biosimilar developer. As a strong R&D driven company offering some of the blockbuster Biosimilar Drugs, we at Hetero Biopharma are bringing about a paradigm shift in the way patients suffering from various chronic conditions are treated. Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide.

Regional Medical Research Centre, NE, Dibrugarh is one of the 26 permanent institutes of Indian Council of Medical Research. The Centre was established on 12th day of July in the year 1982. It covers the most remote and less developed eight states of the north-eastern region of India and is responsible for carrying out Biomedical Research in the region and runs with intramural grant from ICMR and extramural adhoc projects from different funding agencies.

The Maharashtra University of Health Sciences (MUHS) is guided by a strategic agenda providing right direction to the health science education in the State.

Institute of Nano Science and Technology (INST), Mohali (Punjab), an autonomous institution of the Department of Science and Technology (DST), Government of India, has been established under the umbrella of NANO MISSION, initiated by DST to boost research and development in the field of Nanoscience and Nanotechnology in India. INST started its activities on 3rd January 2013 from its transit campus at Mohali, Punjab.

The facility is affiliated with National Institute of Plant Genome Research, New Delhi (NIPGR) and serve to facilitate genotyping services with private service providers and then advanced these, in a focused way, to meet the goal of food and nutritional security through genomics led breeding. The fundamental principle is relatively simple create and charter an entity with express purpose of serving crop or plant varietal genotyping and characterization in India. It will also help to overcome legal hurdles in Material Transfer, IPR protection, etc.

During that time with the help and support of Dr. B.C. Roy an eminet physician and then chief minister of West Bengal, the foundation of the present day Chittaranjan Cancer Hospital (CCH) was laid.The hospital was formally inaugurated by Prof.

The leading edge of Hetero Group, Hetero Biopharma, is steadily establishing itself as a path breaking Biosimilar developer. As a strong R&D driven company offering some of the blockbuster Biosimilar Drugs, we at Hetero Biopharma are bringing about a paradigm shift in the way patients suffering from various chronic conditions are treated. Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide.

The wave of globalization has propelled the expansion of Indian pharma sector. India is amongst the top 10 countries of the world, in terms of volume and value of Pharmaceutical products. Enthusiastic and entrepreneurial efforts have turned Gujarat into the hub of Pharma industry.  The innovative and translational approach of the Indian scientists resulted in paradigm shift from industrial age to knowledge enriched economy.

The Central Drugs Standard Control Organisation under Directorate General of Health Services,Ministry of Health & Family Welfare,Government of India is the National Regulatory Authority (NRA) of India. Its headquarter is located at FDA Bhawan, Kotla Road, New Delhi 110002 and also has six zonal offices,four sub zonal offices,thirteen Port offices and seven laboratories spread across the country.